GT Biopharma Inc (GTBP) — Capital Reinvestment Ratio
Latest as of September 2014:
0.00x
GT Biopharma Inc (GTBP) has a Capital Reinvestment Ratio of 0.00x as of September 2014, meaning it reinvests 0% of its operating cash flow ($45.00K) in capital expenditures ($2.00). See GTBP free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$45.00K
USD
Capital Expenditures
$2.00
USD
Data as of
Sep 2014
Most recent filing
GT Biopharma Inc Capital Reinvestment Ratio (1987–1987)
This chart tracks GT Biopharma Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for GT Biopharma Inc (1987–1987)
Year-by-year Capital Reinvestment Ratio for GT Biopharma Inc from 1987 to 1987. For live market cap and broader valuation context, see GTBP market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 1987 | 1.00x | $50.00K | $50.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow